Key facts
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 06 Mar 2024, 18:19.
Pascal Touchon - 04 Mar 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Signature
- /s/ John Chao, Attorney-in-Fact for Pascal Touchon
- Issuer symbol
- ATRA
- Transactions as of
- 04 Mar 2024
- Net transactions value
- -$17,888
- Form type
- 4
- Filing time
- 06 Mar 2024, 18:19:43 UTC
- Previous filing
- 09 Jan 2024
- Next filing
- 20 May 2024
- SEC
- View on sec.gov
Key filing fact
Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 06 Mar 2024.
Change
- Previous filing in this sequence was filed on 09 Jan 2024.
- Current net transaction value: -$17,888.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
ATRA
transaction
Common Stock
Sale
- Transaction value
- $17,888
- Shares
- -24,844
- Change %
- -1.3%
- Price
- $0.7200
- Shares after
- 1,910,652
- Date
- 04 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement. |
| F2 | The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. |